Correlation Between Reduced IL-1β Levels in Acne Lesions and the Decrease in Acne Inflammatory Lesions Following...

Area of Science:

• Dermatology
• Inflammation Research
• Vitamin D Metabolism

Background:

• Acne vulgaris (AV) involves pro-inflammatory cytokines like IL-1β, IL-6, and IL-8.
• Sebocytes are target cells for vitamin D, which has shown comedolytic effects in animal models.
• The impact of vitamin D on inflammatory acne lesions requires further investigation.

Purpose of the Study:

• To evaluate topical vitamin D's effectiveness in treating AV lesions.
• To investigate vitamin D's anti-inflammatory effects on cytokine modulation.
• To assess the correlation between IL-1β levels and AV severity reduction.

Main Methods:

• A double-blind, randomized, placebo-controlled trial with 64 participants over 8 weeks.
• Participants received either topical vitamin D (cholecalciferol 50 mcg) or placebo, plus topical adapalene 0.1%.
• IL-1β levels were measured using Luminex assays; lesion counts assessed treatment efficacy and side effects.

Main Results:

• A significant correlation was found between reduced IL-1β levels and decreased inflammatory AV lesions (p = 0.028).
• Topical vitamin D significantly reduced inflammatory AV lesions (p = 0.045).
• No significant topical side effects were observed in either group.

Conclusions:

• Topical vitamin D is effective in reducing pro-inflammatory cytokine levels in acne lesions.
• Vitamin D treatment significantly decreases the severity of acne vulgaris.
• The study supports topical vitamin D as a safe and effective therapeutic option for AV.